24 Aug 2026
08:00 CEST |
VALERIO THERAPEUTICS |
Valerio Therapeutics Announces Signing of Definitive Agreements for the Acquisition of Etherna Immunotherapies, Building a Leading Platform in Targeted RNA, and €40.25 Million PIPE Financing From New and Existing Investors
|
20103010 Biotechnology |
Mergers, Acquisitions, Transfers |
24 Aug 2026
08:00 CEST |
VALERIO THERAPEUTICS |
Valerio Therapeutics annonce la signature d’accords définitifs en vue de l’acquisition d’Etherna Immunotherapies, créant ainsi un leader mondial des médicaments à base d’ARN ciblés et d’un financement de 40,25 millions d’euros auprès...
|
20103010 Biotechnology |
Mergers, Acquisitions, Transfers |
17 Aug 2026
08:00 CEST |
VALERIO THERAPEUTICS |
Valerio Therapeutics et Etherna Immunotherapies progressent vers la finalisation de la documentation relative à l’Acquisition envisagée
|
20103010 Biotechnology |
Corporate life |
17 Aug 2026
08:00 CEST |
VALERIO THERAPEUTICS |
Valerio Therapeutics and Etherna Immunotherapies Progress Towards Finalisation of Transaction Documentation Regarding the Contemplated Acquisition
|
20103010 Biotechnology |
Corporate life |
16 Jul 2026
09:07 CEST |
VALERIO THERAPEUTICS |
Valerio Therapeutics annonce une collaboration de développement avec Abivax et met à jour son pipeline
|
20103010 Biotechnology |
News contracts |
16 Jul 2026
09:07 CEST |
VALERIO THERAPEUTICS |
Valerio Therapeutics Announces Development Collaboration with Abivax and Provides Pipeline Update
|
20103010 Biotechnology |
News contracts |
01 Jul 2026
09:22 CEST |
VALERIO THERAPEUTICS |
Valerio Therapeutics annonce une offre ferme en vue de l’acquisition envisagée d’Etherna Immunotherapies, créant ainsi un leader mondial des médicaments à base d’ARN ciblés
|
20103010 Biotechnology |
Corporate life |
01 Jul 2026
09:22 CEST |
VALERIO THERAPEUTICS |
Valerio Therapeutics Announces Binding Offer for the Proposed Acquisition of Etherna Immunotherapies, Creating a Global Leader in Targeted RNA Medicines
|
20103010 Biotechnology |
Corporate life |
16 Jun 2026
19:42 CEST |
VALERIO THERAPEUTICS |
Valerio Therapeutics nomme Gilles Besin au poste de Directeur Général et annonce les résultats de son Assemblée Générale Annuelle
|
20103010 Biotechnology |
General meeting / Board Meeting |
16 Jun 2026
19:42 CEST |
VALERIO THERAPEUTICS |
Valerio Therapeutics Appoints Gilles Besin as Chief Executive Officer and Announces Results of its Annual General Meeting
|
20103010 Biotechnology |
General meeting / Board Meeting |
18 May 2026
18:27 CEST |
VALERIO THERAPEUTICS |
Valerio Therapeutics Announces Binding Term-Sheet for Collaboration and Exclusive License With Seed-Stage Biotech Company
|
20103010 Biotechnology |
Alliances and agreements |
18 May 2026
18:27 CEST |
VALERIO THERAPEUTICS |
Valerio Therapeutics annonce la signature d’une term-sheet engageante en vue d’une collaboration et d’une licence exclusive avec une société de biotechnologie en phase d’amorçage
|
20103010 Biotechnology |
Alliances and agreements |
04 May 2026
08:45 CEST |
VALERIO THERAPEUTICS |
Valerio Therapeutics annonce le lancement d’InVimmune, une nouvelle société dédiée au développement d’approches différenciées de thérapie cellulaire in vivo
|
20103010 Biotechnology |
New |
04 May 2026
08:45 CEST |
VALERIO THERAPEUTICS |
Valerio Therapeutics Announces the Launch of InVimmune, a New Company Dedicated to Developing Differentiated in Vivo Cell Therapy Approaches
|
20103010 Biotechnology |
New |
29 Apr 2026
17:45 CEST |
VALERIO THERAPEUTICS |
Valerio Therapeutics publie ses résultats annuels 2025, son rapport financier annuel et confirme la transformation stratégique de son modèle opérationnel
|
20103010 Biotechnology |
Income |
29 Apr 2026
17:45 CEST |
VALERIO THERAPEUTICS |
Valerio Therapeutics Publishes Its 2025 Annual Results and Annual Financial Report, and Confirms the Strategic Transformation of Its Operating Model
|
20103010 Biotechnology |
Income |
17 Dec 2025
10:57 CET |
VALERIO THERAPEUTICS |
Valerio Therapeutics Announces the Appointment of Professor Eric Vivier as Observer to Its Board of Directors
|
20103010 Biotechnology |
Journal / appointments |
17 Dec 2025
10:57 CET |
VALERIO THERAPEUTICS |
VALERIO THERAPEUTICS ANNONCE LA DESIGNATION DU PROFESSEUR ERIC VIVIER EN QUALITE D’OBSERVATEUR DE SON CONSEIL D’ADMINISTRATION
|
20103010 Biotechnology |
Journal / appointments |
12 Dec 2025
18:29 CET |
VALERIO THERAPEUTICS |
Valerio Therapeutics announces the designation Of Professor Eric Vivier as Observer to its Board of Directors
|
20103010 Biotechnology |
Corporate life |
12 Dec 2025
18:27 CET |
VALERIO THERAPEUTICS |
Valerio Therapeutics annonce la désignation Du Professeur Eric Vivier en qualité d’Observateur de son Conseil d’Administration
|
20103010 Biotechnology |
Corporate life |
26 Nov 2025
18:00 CET |
VALERIO THERAPEUTICS |
Cooptation d'Antonin de Fougerolles en qualité d' Administrateur de Valerio Therapeutics
|
20103010 Biotechnology |
General meeting / Board Meeting |
26 Nov 2025
18:00 CET |
VALERIO THERAPEUTICS |
Valerio Therapeutics announces changes in the composition of its Board of
|
20103010 Biotechnology |
General meeting / Board Meeting |
31 Oct 2025
17:39 CET |
VALERIO THERAPEUTICS |
PROJET DE FUSION ENTRE VALERIO THERAPEUTICS ET SA FILIALE VALOUR BIO
|
20103010 Biotechnology |
Mergers, Acquisitions, Transfers |
31 Oct 2025
17:38 CET |
VALERIO THERAPEUTICS |
PROPOSED MERGER BETWEEN VALERIO THERAPEUTICS AND ITS SUBSIDIARY VALOUR BIO
|
20103010 Biotechnology |
Mergers, Acquisitions, Transfers |
31 Oct 2025
17:36 CET |
VALERIO THERAPEUTICS |
Projet de fusion entre Valerio Therapeutics et sa filiale Valour Bio
|
20103010 Biotechnology |
Mergers, Acquisitions, Transfers |
16 Oct 2025
11:02 CEST |
VALERIO THERAPEUTICS |
VALERIO THERAPEUTICS ANNOUNCES THE COMPLETION OF A CAPITAL INCREASE WITH CANCELLATION OF PREFERENTIAL SUBSCRIPTION RIGHTS
|
20103010 Biotechnology |
Change in Capital |
16 Oct 2025
11:01 CEST |
VALERIO THERAPEUTICS |
Valerio Therapeutics réalisation d'une augmentation de capital avec surpression du droit préférentiel de souscription
|
20103010 Biotechnology |
Change in Capital |
09 Jul 2025
16:42 CEST |
VALERIO THERAPEUTICS |
Mise à disposition du Rapport Financier Annuel 2024
|
20103010 Biotechnology |
Corporate life |
09 Jul 2025
16:41 CEST |
VALERIO THERAPEUTICS |
Publication of the Annual Report 2024
|
20103010 Biotechnology |
Legal |
06 May 2025
17:06 CEST |
VALERIO THERAPEUTICS |
Valerio Therapeutics : Report de la publication du rapport financier annuel 2024, de l’arrêté et de l’approbation des comptes 2024
|
20103010 Biotechnology |
Income |
06 May 2025
17:06 CEST |
VALERIO THERAPEUTICS |
Valerio Therapeutics: Postponement of 2024 Annual Financial Report Publication and the Approval of Financial Statements
|
20103010 Biotechnology |
Income |
19 Mar 2025
15:27 CET |
VALERIO THERAPEUTICS |
VALERIO THERAPEUTICS: List of the Board Members Positions Held in Other Companies as of March 19, 2025
|
20103010 Biotechnology |
General meeting / Board Meeting |
19 Mar 2025
12:30 CET |
VALERIO THERAPEUTICS |
VALERIO THERAPEUTICS : RAPPORT DU CONSEIL D’ADMINISTRATION
|
20103010 Biotechnology |
General meeting / Board Meeting |
19 Mar 2025
12:30 CET |
VALERIO THERAPEUTICS |
Valerio Therapeutics: Report of the Board of Directors
|
20103010 Biotechnology |
General meeting / Board Meeting |
03 Mar 2025
17:35 CET |
VALERIO THERAPEUTICS |
Valerio Therapeutics annonce avoir mis fin au contrat de liquidité conclu le 29 octobre 2018 avec KEPLER CHEUVREUX
|
20103010 Biotechnology |
General meeting / Board Meeting |
03 Mar 2025
17:35 CET |
VALERIO THERAPEUTICS |
Valerio Therapeutics Announces the Termination of the Liquidity Contract Entered Into on 29 October 2018 With KEPLER CHEUVREUX
|
20103010 Biotechnology |
General meeting / Board Meeting |
04 Feb 2025
10:35 CET |
VALERIO THERAPEUTICS |
Valerio Therapeutics Announces Strategic Refocus
|
20103010 Biotechnology |
General meeting / Board Meeting |
04 Feb 2025
10:35 CET |
VALERIO THERAPEUTICS |
Valerio Therapeutics annonce un recentrage stratégique
|
20103010 Biotechnology |
General meeting / Board Meeting |
15 Nov 2024
08:00 CET |
VALERIO THERAPEUTICS |
Meeting of the Board of Directors of Valerio Therapeutics S.A. on November 13, 2024
|
20103010 Biotechnology |
Corporate life |
15 Nov 2024
08:00 CET |
VALERIO THERAPEUTICS |
Réunion du Conseil d'administration de Valerio Therapeutics S.A. du 13 novembre 2024
|
20103010 Biotechnology |
Corporate life |
30 Sep 2024
22:40 CEST |
VALERIO THERAPEUTICS |
Valerio Therapeutics Reports its Half-Year 2024 Financial Results and Provides an Update on its Activities
|
20103010 Biotechnology |
Corporate life |
30 Sep 2024
22:40 CEST |
VALERIO THERAPEUTICS |
Valerio Therapeutics Annonce ses Résultats Financiers du Premier Semestre 2024 et Fait le point sur ses Activités
|
20103010 Biotechnology |
Corporate life |
30 Sep 2024
07:00 CEST |
VALERIO THERAPEUTICS |
Valerio Therapeutics acquiert Emglev Therapeutics, une société spécialisée dans les thérapies à base d'anticorps à domaine unique
|
20103010 Biotechnology |
Mergers, Acquisitions, Transfers |
30 Sep 2024
07:00 CEST |
VALERIO THERAPEUTICS |
Valerio Therapeutics Acquires Emglev Therapeutics, a Single-Domain Antibody-Based Therapeutics Company
|
20103010 Biotechnology |
Mergers, Acquisitions, Transfers |
05 Aug 2024
19:18 CEST |
VALERIO THERAPEUTICS |
VALERIO THERAPEUTICS : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITÉ CONTRACTÉ AVEC KEPLER CHEUVREUX
|
20103010 Biotechnology |
Corporate life |
05 Aug 2024
19:18 CEST |
VALERIO THERAPEUTICS |
Half-Year Liquidity Contract Statement for Valerio Therapeutics
|
20103010 Biotechnology |
Corporate life |
05 Jun 2024
07:00 CEST |
VALERIO THERAPEUTICS |
Valerio Therapeutics : compte rendu de l’assemblée générale mixte du 4 juin 2024
|
20103010 Biotechnology |
General meeting / Board Meeting |
05 Jun 2024
07:00 CEST |
VALERIO THERAPEUTICS |
Valerio Therapeutics: Report on the Combined General Meeting of June 4, 2024
|
20103010 Biotechnology |
General meeting / Board Meeting |
22 May 2024
20:46 CEST |
VALERIO THERAPEUTICS |
Valerio Therapeutics fait une mise à jour du développement clinique de son essai clinique de phase 1/2 VIO-01
|
20103010 Biotechnology |
Other subject |
22 May 2024
20:46 CEST |
VALERIO THERAPEUTICS |
Valerio Therapeutics Provides Clinical Development Update on Its Phase 1/2 VIO-01 Clinical Trial
|
20103010 Biotechnology |
Other subject |